skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i,

I'm concerned with all the sabre rattling leading to a US/China trade war. Of particular concern are American companies that are needing China as the engine for growth. 1. Do you think this is a valid concern? 2. Would you position your portfolio more domestically/defensively for a trade war? 3. What would be some good alternatives to these three companies that are more domestic (or Western) centric for growth?

TIA!
Read Answer Asked by Wayne on May 19, 2020
Q: I currently hold GUARDANT, ALTERYX and ROKU in one account. As a basket they collectively just can’t seem to stay above water. Are you still optimistic on these names or has your opinion changed? Should I remain patient or would you swap any for VEEV?
Read Answer Asked by Marty on May 19, 2020
Q: Bloomberg Businessweek of May 4, 2020 has an article "Tock to Go Brings Fine Dining To the Socially Distant" in which mentioned that Tock is a comprehensive platform built to fundamentally change the way restaurants think about and run their business. This includes a robust reservation, guest, and table management system for restaurants of all sizes across the globe. It sounds a very powerful platform for the industry mentioned. I am not sure if Tock has a stock. If it does, will it be a competitor to LSDP?

Thank you as always for helping us navigating through this crazy time.
Lin
Read Answer Asked by Lin on May 19, 2020
Q: Hi : What's your view on Monster Beverage? It screens well (based on pre-CoVid data) but I am unsure how its business will be affected by the CoVid situation. Are there other companies in the same space that you like better?

Thanks for your insight,

JohnR
Read Answer Asked by John on May 19, 2020
Q: San Diego small cap Sorrento Therapeutics stock exploded on Friday. Sorrento said it's STI-1499 antibody demonstrated 100% inhibition of the COVID-19 virus infection of healthy cells in pre-clinical trials. The company advised full results of the experiment will soon be submitted to a "peer-reviewed publication." A week ago they announced an agreement to work with Mount Sinai Health System on a phase one clinical trial of the retained plasma of 15000 covid patients commencing in Q3.
The company appears to be claiming that STI-1499 at the pre-clinical stage is a cure which they plan to develop as a stand alone treatment as well as the 1st part of an antibody cocktail treatment which they are developing in cooperation with Mount Sinai for the same purpose.
Generally speaking I am an investor, not a gambler but am interested in your views/comments on this company and it's financial situation, which is why I mention the word "gamble". Would you invest/gamble ? on this co. at this stage or sit back and wait for further confirmation of test results.

John
Read Answer Asked by JOHN on May 18, 2020
Q: Hello 5i team. Trying to make some money on the home fitness hibernation trend. Looking at Nautilus which has quadrupled (how did I miss that ?!?!?) in the last 6 months for my TFSA. The bride says pass, that I should go with Peloton instead, which has a higher profile, whose shares are also on an upward trajectory and which she believes trumps Nautilus in 'the cool factor'. Your insights are always appreciated.
Read Answer Asked by Asher on May 16, 2020
Q: Is Quidel worth owning on its merits -- quite apart from the diagnostic testing that's given it an incredible pop in the last month? As a health care play, would you prefer this one over Teladoc, (TDOC) for instance. I realize they are not "exactly equivalent" in terms of their intrinsic businesses, but I am looking for solid growth story in the health field.
Read Answer Asked by Sylvia on May 15, 2020
Q: Hi 5i team,
I follow a number of the stay-at-home stocks but question their valuations and wonder about their staying power. One that has been on my watchlist for awhile is CHGG. The stock price jumped recently after a very strong earnings report, so I may have missed the run. It is gathering analyst support for its on-line education platform for courses, tutoring and reference material for high school and college students. With a number of universities in Canada and the U.S. keeping campuses closed at least until the January semester, does CHGG have some staying power for its on-line educational services? What are your thoughts on CHGG?
Thanks again for the insight.
Dave
Read Answer Asked by Dave on May 15, 2020
Q: Hi, I'm looking to add to the fintech world. I'm sure online purchases and contact-less (cash less) payments only continue to increase.

What is your favorite growth stock in this category (1) overall, and (2) one that is well positioned to succeed in both the physical space (contact less at stores) and online (web payments).

C.
Read Answer Asked by Cameron on May 15, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!